Health Catalyst, Inc.
HCAT Nasdaq
SEC CIK 1636422
Follow Health Catalyst
Weekly email: filings, results
Revenue, last quarter
$56.3M
−26.3% vs same quarter last year
Net income
$40.5M
+282.2% vs same quarter last year
EPS, diluted
$0.53
+265.6% vs same quarter last year
Operating cash flow
−$1.9M
−304.1% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $311.1M | −$178M |
| FY24 | $306.6M | −$69.5M |
| FY23 | $295.9M | −$118.1M |
| FY22 | $276.2M | −$137.4M |
| FY21 | $241.9M | −$153.2M |
| FY20 | $188.8M | −$115M |
| FY19 | $154.9M | −$60.1M |
| FY18 | $112.6M | −$62M |
| FY17 | $73.1M | −$47M |
| FY16 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −51.7% | −57.2% |
| FY24 | −22.8% | −22.7% |
| FY23 | −42.9% | −39.9% |
| FY22 | −50.7% | −49.7% |
| FY21 | −59.4% | −63.3% |
| FY20 | −50.9% | −60.9% |
| FY19 | −35.4% | −38.8% |
| FY18 | −53.4% | −55.1% |
| FY17 | −62.3% | −64.4% |
| FY16 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$237K |
| FY24 | $12.9M |
| FY23 | −$34.3M |
| FY22 | −$37.4M |
| FY21 | −$33.6M |
| FY20 | −$33.9M |
| FY19 | −$34.2M |
| FY18 | −$42.4M |
| FY17 | −$39.3M |
| FY16 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $5M |
| FY24 | $0 |
| FY23 | $1.8M |
| FY22 | $8.4M |
| FY21 | $0 |
| FY20 | $0 |
| FY19 | $0 |
| FY18 | $8.7M |
| FY17 | $0 |
| FY16 | - |
- Health Catalyst
- Technology median
Show the numbers
| Year | Health Catalyst | Technology median |
|---|---|---|
| FY25 | −57.2% | −2.4% |
| FY24 | −22.7% | −5% |
| FY23 | −39.9% | −6.7% |
| FY22 | −49.7% | −4.4% |
| FY21 | −63.3% | −1.7% |
| FY20 | −60.9% | −3% |
| FY19 | −38.8% | 0% |
| FY18 | −55.1% | 0.8% |
| FY17 | −64.4% | 2% |
| FY16 | - | 2.3% |